Thomas C. Malone
80Patents
12h-index
72Co-inventors
87Inventor score
Filing activity: Mar 13, 1989 → Sep 10, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6765012B2 | 3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors | Chemistry; Metallurgy | 84 | Expired |
| US8512738B2 | Biodegradable intravitreal tyrosine kinase implants | Human Necessities | 58 | Active |
| US8409607B2 | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods | Emerging Cross-Sectional Technologies | 53 | Active |
| US7771742B2 | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods | Emerging Cross-Sectional Technologies | 37 | Active |
| US6458781B1 | Substituted diarylalkyl amides as calcium channel antagonists | Chemistry; Metallurgy | 37 | Expired |
| US6541504B1 | (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors | Chemistry; Metallurgy | 32 | Expired |
| US6747025B1 | Kinase inhibitors for the treatment of disease | Chemistry; Metallurgy | 30 | Expired |
| US5145845A | Substituted 2-carboxylindoles having pharmaceutical activity | Chemistry; Metallurgy | 23 | Expired |
| US7015220B2 | 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors | Chemistry; Metallurgy | 21 | Expired |
| US8968766B2 | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods | Emerging Cross-Sectional Technologies | 19 | Active |
| US7060844B2 | (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors | Chemistry; Metallurgy | 16 | Expired |
| US6423689B1 | Peptidyl calcium channel blockers | Human Necessities | 15 | Expired |
| US5002950A | 7-deazaguanines as immunomodulators | Chemistry; Metallurgy | 12 | Expired |
| US6117841A | Substituted peptidylamine calcium channel blockers | Human Necessities | 12 | Expired |
| US7125908B2 | Treating pain using selective antagonists of persistent sodium current | Human Necessities | 11 | Expired |
| US4921858A | 7-deazaguanines as immunomodulators | Chemistry; Metallurgy | 10 | Expired |
| US7060723B2 | Treating neurological disorders using selective antagonists of persistent sodium current | Human Necessities | 9 | Expired |
| US6197771A | Glutamate (ampa/kainate) receptor antagonists: N-substituted fused azacycloalkylquinoxalinediones | Chemistry; Metallurgy | 7 | Expired |
| US7767718B2 | Treating pain using selective antagonists of persistent sodium current | Human Necessities | 6 | Active |
| US7915443B2 | Sulfoximines as kinase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US7749530B2 | Kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US7705055B2 | Treating neurological disorders using selective antagonists of persistent sodium current | Human Necessities | 4 | Active |
| US9433631B2 | 4-pregenen-11β-17-21-triol-3,20-dione derivatives | Human Necessities | 3 | Active |
| US7977351B2 | Heteroaryl dihydroindolones as kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US9371314B2 | Pyridyl benzothiophenes as kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.